Free Trial

Privia Health Group (PRVA) Stock Forecast & Price Target

Privia Health Group logo
$23.28 +0.16 (+0.69%)
Closing price 09/5/2025 04:00 PM Eastern
Extended Trading
$23.28 0.00 (0.00%)
As of 09/5/2025 06:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Privia Health Group - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Sell
0
Hold
2
Buy
12

Based on 14 Wall Street analysts who have issued ratings for Privia Health Group in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 14 analysts, 2 have given a hold rating, 11 have given a buy rating, and 1 has given a strong buy rating for PRVA.

Consensus Price Target

$28.58
22.78% Upside
According to the 14 analysts' twelve-month price targets for Privia Health Group, the average price target is $28.58. The highest price target for PRVA is $35.00, while the lowest price target for PRVA is $23.00. The average price target represents a forecasted upside of 22.78% from the current price of $23.28.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for PRVA and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Privia Health Group and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PRVA Analyst Ratings Over Time

TypeCurrent Forecast
9/6/24 to 9/6/25
1 Month Ago
8/7/24 to 8/7/25
3 Months Ago
6/8/24 to 6/8/25
1 Year Ago
9/7/23 to 9/6/24
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
11 Buy rating(s)
11 Buy rating(s)
11 Buy rating(s)
12 Buy rating(s)
Hold
2 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$28.58$28.38$27.77$24.86
Forecasted Upside22.78% Upside45.49% Upside19.75% Upside33.21% Upside
Consensus RatingModerate BuyBuyBuyModerate Buy

PRVA Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

PRVA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Privia Health Group Stock vs. The Competition

TypePrivia Health GroupMedical CompaniesS&P 500
Consensus Rating Score
2.93
2.78
2.53
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside22.78% Upside16,022.67% Upside10.35% Upside
News Sentiment Rating
Positive News

See Recent PRVA News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
9/4/2025Stephens
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Jeff Garro
Jeff Garro
Not Rated
Reiterated RatingOverweight$32.00+38.11%
8/29/2025JMP Securities
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
David M. Scharf
Not Rated
Boost TargetMarket Outperform$29.00 ➝ $30.00+37.55%
8/29/2025Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Reiterated RatingOutperform
8/19/2025Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 UpgradeStrong SellHold
8/11/2025Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetOverweight$36.00 ➝ $35.00+70.07%
7/9/2025Evercore ISI
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetOutperform$30.00 ➝ $28.00+30.11%
5/28/2025JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetOverweight$29.00 ➝ $32.00+39.10%
5/27/2025Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetEqual Weight$23.00 ➝ $24.00+2.32%
4/15/2025Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetOutperform$24.00 ➝ $26.00+8.11%
4/10/2025Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$30.00 ➝ $30.00+30.15%
4/10/2025Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$27.00 ➝ $28.00+21.48%
2/28/2025Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$29.00 ➝ $30.00+19.02%
12/16/2024Macquarie
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageOutperform$25.00+19.27%
10/11/2024KeyCorp
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Initiated CoverageOverweight$23.00+34.35%
8/14/2024Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Reiterated RatingOutperform$28.00 ➝ $28.00+44.26%
5/30/2024Baird R W
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong-Buy
5/1/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Lower TargetBuy$28.00 ➝ $24.00+30.43%
3/1/2024UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Lower TargetBuy$31.00 ➝ $29.00+31.28%
3/1/2024TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Lower TargetOutperform$30.00 ➝ $26.00+16.49%
2/26/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Initiated CoverageBuy$33.00 ➝ $25.00+25.63%
2/22/2024Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 DowngradeBuyNeutral$27.00 ➝ $21.00+2.79%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 02:41 PM ET.


PRVA Forecast - Frequently Asked Questions

According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for Privia Health Group is $28.58, with a high forecast of $35.00 and a low forecast of $23.00.

14 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Privia Health Group in the last twelve months. There are currently 2 hold ratings, 11 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" PRVA shares.

According to analysts, Privia Health Group's stock has a predicted upside of 22.78% based on their 12-month stock forecasts.

Over the previous 90 days, Privia Health Group's stock had 1 upgrade by analysts.

Privia Health Group has been rated by research analysts at Citigroup, Evercore ISI, JMP Securities, Piper Sandler, Stephens, and Zacks Research in the past 90 days.

Analysts like Privia Health Group more than other "medical" companies. The consensus rating score for Privia Health Group is 2.93 while the average consensus rating score for "medical" companies is 2.78. Learn more on how PRVA compares to other companies.


This page (NASDAQ:PRVA) was last updated on 9/6/2025 by MarketBeat.com Staff
From Our Partners